This topic contains a solution. Click here to go to the answer

Author Question: Pertaining to fainting: a. sincopal b. syncopal c. sinkaple[br][br][b][color=#7BCCB5]Question ... (Read 53 times)

codyclark

  • Hero Member
  • *****
  • Posts: 538
Pertaining to fainting:
 
  a. sincopal
  b. syncopal
  c. sinkaple

Question 2

Inability to hold urine in bladder:
 
  a. incontenence
  b. incontinence
  c. incontinance



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Zebsrer

  • Sr. Member
  • ****
  • Posts: 284
Answer to Question 1

B

Answer to Question 2

B




codyclark

  • Member
  • Posts: 538
Reply 2 on: Jun 27, 2018
Wow, this really help


skipfourms123

  • Member
  • Posts: 343
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

GI conditions that will keep you out of the U.S. armed services include ulcers, varices, fistulas, esophagitis, gastritis, congenital abnormalities, inflammatory bowel disease, enteritis, colitis, proctitis, duodenal diverticula, malabsorption syndromes, hepatitis, cirrhosis, cysts, abscesses, pancreatitis, polyps, certain hemorrhoids, splenomegaly, hernias, recent abdominal surgery, GI bypass or stomach stapling, and artificial GI openings.

Did you know?

Oxytocin is recommended only for pregnancies that have a medical reason for inducing labor (such as eclampsia) and is not recommended for elective procedures or for making the birthing process more convenient.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library